Literature DB >> 25513989

Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma.

Ziwei Liao1, Lingling Zhou, Chunyan Wang, Zhifeng He, Xu Wang, Xiaodan Luo, Shaohua Chen, Lijian Yang, Huo Tan, Yangqiu Li.   

Abstract

Abnormal expression of key signaling molecules and defective T-cell function play a crucial role in the pathogenesis of T-cell immunodeficiency in hematological malignancies. To understand the molecular basis of T-cell signaling abnormalities and TCRζ chain deficiencies in T- and NK/T-cell lymphoma, the expression level of the TCRζ, ZAP-70, and FcɛRIγ genes in peripheral blood mononuclear cells from 25 patients with T-cell lymphoma, 16 patients with NK/T-cell lymphoma (NK/T-CL), and 26 healthy individuals was determined. In addition, their relationship with disease stage and TCRζ 3' untranslated region (3'UTR) splice variants was analyzed in this study. The expression level of all three genes was significantly altered with disease progression, and a decreasing trend was found in patients compared with healthy controls. TCRζ and ZAP-70 were significantly positively related in all samples, and a negative relationship between TCRζ and FcɛRIγ was significantly lost in NK/T-CL patients. Moreover, distinct expression patterns were defined for patient groups with different TCRζ 3'UTR isoforms. In conclusion, a lower expression pattern for all three genes may indicate a weaker immune status based on reduced TCRζ and ZAP-70 expression without the complementary effects of FcɛRIγ, while aberrant TCRζ 3'UTR splicing may contribute to T-cell receptor (TCR) signaling regulation in T cells from patients with T- and NK/T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25513989      PMCID: PMC4337460          DOI: 10.1089/dna.2014.2693

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  33 in total

1.  Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.

Authors:  Karin Ekström Smedby; Henrik Hjalgrim; Johan Askling; Ellen T Chang; Henrik Gregersen; Anna Porwit-MacDonald; Christer Sundström; Måns Akerman; Mads Melbye; Bengt Glimelius; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2006-01-04       Impact factor: 13.506

2.  Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma.

Authors:  Yangqiu Li; Shaohua Chen; Lijian Yang; Si Chen; Chunlan Lin; Liang Wang; Yuhong Lu; Suxia Geng; Xin Du; Christian A Schmidt
Journal:  Hematology       Date:  2011-05       Impact factor: 2.269

3.  Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk.

Authors:  M C Fargnoli; R L Edelson; C L Berger; S Chimenti; C Couture; T Mustelin; R Halaban
Journal:  Leukemia       Date:  1997-08       Impact factor: 11.528

4.  Upregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML.

Authors:  Xianfeng Zha; Shaohua Chen; Lijian Yang; Li Shi; Bo Li; Xiuli Wu; Yuhong Lu; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2012-10-11       Impact factor: 3.311

Review 5.  The T cell receptor: critical role of the membrane environment in receptor assembly and function.

Authors:  Matthew E Call; Kai W Wucherpfennig
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients.

Authors:  Shaohua Chen; Xianfeng Zha; Lijian Yang; Bo Li; Zhong Liye; Yangqiu Li
Journal:  Hematology       Date:  2011-01       Impact factor: 2.269

7.  Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3'-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus.

Authors:  Bhabadeb Chowdhury; Christos G Tsokos; Sandeep Krishnan; James Robertson; Carolyn U Fisher; Rahul G Warke; Vishal G Warke; Madhusoodana P Nambiar; George C Tsokos
Journal:  J Biol Chem       Date:  2005-03-02       Impact factor: 5.157

8.  Non-Hodgkin's lymphomas, version 4.2014.

Authors:  Andrew D Zelenetz; Leo I Gordon; William G Wierda; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; Nancy Bartlett; John C Byrd; Myron S Czuczman; Luis E Fayad; Richard I Fisher; Martha J Glenn; Nancy Lee Harris; Richard T Hoppe; Steven M Horwitz; Christopher R Kelsey; Youn H Kim; Susan Krivacic; Ann S LaCasce; Auayporn Nademanee; Pierluigi Porcu; Oliver Press; Rachel Rabinovitch; Nishitha Reddy; Erin Reid; Ayman A Saad; Lubomir Sokol; Lode J Swinnen; Christina Tsien; Julie M Vose; Joachim Yahalom; Nadeem Zafar; Mary Dwyer; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2014-09       Impact factor: 11.908

Review 9.  Novel therapeutic agents for cutaneous T-Cell lymphoma.

Authors:  Salvia Jain; Jasmine Zain; Owen O'Connor
Journal:  J Hematol Oncol       Date:  2012-05-17       Impact factor: 17.388

10.  Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.

Authors:  Hamilton L Gimenes-Teixeira; Antonio R Lucena-Araujo; Guilherme A Dos Santos; Dalila L Zanette; Priscila S Scheucher; Luciana C Oliveira; Leandro F Dalmazzo; Wilson A Silva-Júnior; Roberto P Falcão; Eduardo M Rego
Journal:  Exp Hematol Oncol       Date:  2013-04-08
View more
  3 in total

1.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

2.  Molecular alterations in the TCR signaling pathway in patients with aplastic anemia.

Authors:  Bo Li; Lixing Guo; Yuping Zhang; Yankai Xiao; Mingjuan Wu; Lingling Zhou; Shaohua Chen; Lijian Yang; Xiang Lu; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2016-03-31       Impact factor: 17.388

3.  Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.

Authors:  Qin Yang; Kaihu Li; Xin Li; Jing Liu
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.